Navigation Links
Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
Date:7/9/2012

PARIS, July 9, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) today reported data from its ongoing Phase 2/3 study evaluating the efficacy of OBI-1, an investigational recombinant porcine factor VIII (FVIII), for the treatment of serious bleeds in people with acquired hemophilia A. According to the interim analysis, seven out of seven trial participants receiving OBI-1 experienced control and subsequent resolution of their bleeds. Edward Gomperts, MD, Attending Hematologist and Director of Clinical Research, Clinical Investigation Center at Children's Hospital Los Angeles and Consultant to Inspiration, presented the findings in an oral presentation at the 2012 World Federation of Hemophilia (WFH) World Congress in Paris.

Acquired hemophilia A is a rare, sometimes life-threatening bleeding disorder that is caused by the development of autoantibodies (inhibitors) against FVIII, a key protein contributing to normal coagulation of blood. The antibodies render the native factor VIII ineffective in promoting clotting. Treatment of acquired hemophilia can be challenging, because the antibodies will attack any human form of FVIII. OBI-1 is designed to avoid recognition by antibodies to human FVIII. People with inhibitors to human FVIII may respond to porcine FVIII, replacing the missing step in their coagulation cascade."People with acquired hemophilia currently have limited treatment options to control serious bleeding episodes. These preliminary findings are encouraging and suggest that further investigation of the efficacy and safety of OBI-1 in this population is warranted," said Dr. Gomperts.

A second Accur8 Phase 2/3 clinical trial is also underway to evaluate OBI-1's ability to control bleeding in people with congenital hemophilia A with inhibitors and the safety of this drug in this population.

As part of Inspiration's expanded presence at the WFH World Congress, the company will host a symposium tomorrow
'/>"/>

SOURCE Inspiration Biopharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
2. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
4. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
5. 2012 Pharmaceutical Diversification Trends, Egypt & Saudi Arabia Pharmaceutical Markets Analyzed in New Research Reports
6. Herborium Group Reports Record 6 Month Revenues
7. Kewaunee Scientific Reports Significantly Improved Results for Fourth Quarter
8. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
9. HealthWarehouse.com Reports 82% Year-Over-Year Revenue Growth
10. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
11. China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
(Date:5/28/2015)...  IRIDEX Corporation (NASDAQ: IRIX ) today announced that ... Mackaness is scheduled to present at the LD Micro ... in Los Angeles . A ... the Event Calendar of the Investors section of IRIDEX,s website ... be available shortly after the conclusion of the presentation and ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 ... has announced the addition of the "United ... report to their offering.      ... medical adhesives in the United States ... through 2020 Medical device manufacturers ...
Breaking Medicine Technology:Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3
... Minn., April 16, 2008 A new Mayo,Clinic ... protect against,mild cognitive impairment, a disorder of the ... This study will be presented at the,American Academy ... 16., Individuals with mild cognitive impairment can ...
... Support Moving Forward with a planned IND Filing for Novavax,s ... Seasonal Influenza Vaccine ... NVAX ) said today that it has received positive results ... influenza vaccine candidate. These findings will enable Novavax to,complete its ...
Cached Medicine Technology:Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 3
(Date:5/29/2015)... Austin, TX (PRWEB) May 29, 2015 ... Austin, Texas , Company website: http://www.carsonenergy.com ... to decline rapidly, due to the boom in US ... Saudi Arabia, in order to regain market share from ... capacity. They realized by putting more oil out into ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 Testosterone Centers ... the DFW area, is opening a new center in the ... the rest of the Mid Cities. Located on the south ... Road in Hurst, the new testosterone center will open in ... women who suffer from low testosterone. , Like TCT’s other ...
(Date:5/29/2015)... BETHESDA, MARYLAND (PRWEB) May 29, 2015 ... changes in the management of medical data. , Today ... on Electronic Health Records (EHR). The “ Report ... Status and Future Direction of EHRs ” was released ... (JAMIA) jamia.org and represents an evolutionary ...
(Date:5/29/2015)... Tampa, Florida (PRWEB) May 29, 2015 ... was affecting some nearby residents for Three Valleys Municipal ... a Three Valleys MWD engineer working on the project ... better than the old barrier and are much better ... the results; our Acoustiblok representative helped us throughout the ...
(Date:5/29/2015)... May 28th, TheCelebrityDresses.com released their new range of exclusively ... of the styles in their new collection were priced ... styles of sexy cocktail dresses and 100 cheap bridesmaid ... with the new release are color blocks, exclusively designed ... the new styles are made of carefully selected fine ...
Breaking Medicine News(10 mins):Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 2Health News:AMIA Issues Report on Electronic Health Records - EHR-2020 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2
... WASHINGTON, March 28 Thousands of epilepsy advocates, caregivers, ... celebrities at the nation,s Capitol today to support the ... two years, the event has raised more than $2 ... event is expected to increase those numbers significantly. Money ...
... could replace anti-clotting drug warfarin for many patients, researchers ... implanted device may soon replace the anti-clotting drug warfarin ... with atrial fibrillation, a new study suggests. , People ... stroke, the researchers noted, and typically need to take ...
... in era of rising costs , , FRIDAY, March 27 (HealthDay ... national health care reform when she was first lady in ... are working -- are without health insurance. , That finding ... a state-by-state picture of people foregoing insurance because of rising ...
... Drug-eluting stents were safe and superior to bare metal ... "real-world" patients enrolled in a nationwide registry of cardiovascular ... , The findings were presented today at the ... Scientific Session. They also appear online in the ...
... (NYSE: NUS ) announced that more than 100,000 ... the company,s distributors and customers who have purchased Epoch Baobab ... company has donated $0.25 from the sale of every Epoch ... Foundation,s Seeds of Hope reforestation project. "When someone purchases a ...
... Earnings Guidance to a Minimum of $0.25 per diluted ... Service Corporation (Nasdaq: PRSC ) today announced ... December 31, 2008. Included in the results is ... related to the Company,s intangible assets, which, when added ...
Cached Medicine News:Health News:Video: Celebrities and Thousands of Walkers Unite at Nation's Capitol to Raise Awareness About Seizures and Epilepsy 2Health News:Video: Celebrities and Thousands of Walkers Unite at Nation's Capitol to Raise Awareness About Seizures and Epilepsy 3Health News:New Device Treats Common Heart Rhythm Disorder 2Health News:New Device Treats Common Heart Rhythm Disorder 3Health News:One in Five Working Adults Said to Lack Health Insurance 2Health News:Drug-eluting stents found safe, superior to bare metal stents 2Health News:Nu Skin Charitable Promotion Reaches Important Milestone: 100,000 Trees Donated to African Nation of Malawi 2Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 2Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 3Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 4Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 5Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 6Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 7Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 8Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 9Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 10Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 11Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 12Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 13Health News:Providence Service Corporation Releases Fourth Quarter and Audited Year End 2008 Results 14
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: